首页 | 本学科首页   官方微博 | 高级检索  
     


Development of pH‐sensitive nanogels for cancer treatment using crosslinked poly(aspartic acid‐graft‐imidazole)‐block‐poly(ethylene glycol)
Authors:Taehoon Sim  Chaemin Lim  Young Hun Cho  Eun Seong Lee  Yu Seok Youn  Kyung Taek Oh
Affiliation:1. College of Pharmacy, Chung‐Ang University, 84 Heukseok‐Ro, Dongjak, Seoul 06974, South Korea;2. Department of Biotechnology, The Catholic University of Korea, 43‐1 Yeokgok 2‐dong, Wonmi, Bucheon, Gyeonggi‐do 14662, South Korea;3. School of Pharmacy, Sungkyunkwan University, 300 Cheoncheon‐dong, Jangan‐gu, Suwon 16419, South Korea
Abstract:pH‐sensitive nanogels (NGs) based on poly(aspartic acid‐graft‐imidazole)‐poly(ethylene glycol) were developed using linear PEG with different molecular weights (2000 and 4000 Da) as crosslinkers. The pH‐sensitive NGs showed reversible size changes during continuously alternating pH changes. The anticancer treatment potential of pH‐sensitive NGs was studied using a model drug, irinotecan (IRI). IRI‐loaded NGs (ILNs) showed different drug release kinetics in acidic versus neutral pH, in addition to pH‐dependent cytotoxicity. Due to its longer crosslinker, ILN 4 (crosslinked with PEG 4000) showed faster IRI release and a greater magnitude of IRI release than ILN 2 (crosslinked with PEG 2000), resulting in greater cytotoxicity against HCT 116 colorectal cancer cells. These pH‐sensitive NGs could potentially be used in cancer treatment by mediating the accumulation and release of IRI from ILNs in the acidic tumor environment and by reducing systemic toxicity due to reversible swelling–shrinkage. © 2018 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2018 , 135, 46268.
Keywords:crosslinking  drug delivery systems  nanoparticles  stimuli‐sensitive polymers  swelling
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号